Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (4): 405-413.doi: 10.3969/j.issn.1000-6621.2019.04.008
• Original Articles • Previous Articles Next Articles
Li-ming YAO,Chen-guang JIA,Zhuo LI,Zhao-liang DONG,lian-bo WANG,Feng-sheng LIU()
Received:
2018-12-24
Online:
2019-04-10
Published:
2019-04-08
Contact:
Feng-sheng LIU
E-mail:15633035975@163.com
Li-ming YAO,Chen-guang JIA,Zhuo LI,Zhao-liang DONG,lian-bo WANG,Feng-sheng LIU. Clinical study on the reasons and therapeutic scheme of postoperative recurrence of spinal tuberculosis in lumbosacral portion[J]. Chinese Journal of Antituberculosis, 2019, 41(4): 405-413. doi: 10.3969/j.issn.1000-6621.2019.04.008
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.04.008
临床资料 | 观察组(15例) | 对照组(69例) | 统计检验值 | P值 |
---|---|---|---|---|
病变受累节段[例(构成比,%)] | χ2=1.80 | 0.242 | ||
2个椎体 | 7(46.7) | 45(65.2) | ||
≥3个椎体 | 8(53.3) | 24(34.8) | ||
并发其他部位结核[例(构成比,%)] | χ2=5.24 | 0.022 | ||
是 | 9(60.0) | 20(29.0) | ||
否 | 6(40.0) | 49(71.0) | ||
白蛋白(g/L, | 35.56±6.04 | 38.71±5.25 | t=2.05 | 0.043 |
红细胞沉降率[mm/1h,M(Q1,Q3)] | 56.0(33.0,80.0) | 43.0(28.5,73.5) | U=430.50 | 0.309 |
血红蛋白(g/L, | 114.13±20.27 | 121.33±22.90 | t=1.12 | 0.264 |
术前抗结核治疗时间[周,M(Q1,Q3)] | 2.0(2.0,5.5) | 2.0(1.0,4.0) | U=408.0 | 0.189 |
手术入路[例(构成比,%)] | χ2=3.66 | 0.160 | ||
单纯前路 | 9(60.0) | 36(52.2) | ||
单纯后路 | 3(20.0) | 5(7.2) | ||
前后路联合 | 3(20.0) | 28(40.6) | ||
手术彻底清除病灶[例(构成比,%)] | χ2=12.39 | 0.000 | ||
是 | 7(46.7) | 60(87.0) | ||
否 | 8(53.3) | 9(13.0) | ||
植骨融合[例(构成比,%)] | χ2=7.90 | 0.010 | ||
是 | 8(53.3) | 59(85.5) | ||
否 | 7(46.7) | 10(14.5) | ||
内固定[例(构成比,%)] | χ2=1.46 | 0.242 | ||
是 | 8(53.3) | 48(69.6) | ||
否 | 7(46.7) | 21(30.4) | ||
术后规范抗结核治疗[例(构成比,%)] | χ2=21.84 | 0.000 | ||
是 | 9(60.0) | 62(89.9) | ||
否 | 6(40.0) | 7(10.1) | ||
耐药[例(构成比,%)] | χ2=4.45 | 0.035 | ||
是 | 5(33.3) | 8(11.6) | ||
否 | 10(66.7) | 61(88.4) |
因素 | β值 | s | Wald χ2 值 | P值 | OR(95%CI)值 |
---|---|---|---|---|---|
术前白蛋白水平<35g/L | 1.99 | 0.99 | 4.01 | 0.045 | 7.32(1.04~51.28) |
手术病灶清除不彻底 | 3.23 | 1.08 | 8.99 | 0.003 | 25.17(3.06~207.29) |
未行植骨融合 | 2.24 | 1.08 | 4.30 | 0.038 | 9.38(1.13~77.90) |
术后应用抗结核药物不规范 | 3.02 | 1.43 | 4.43 | 0.035 | 20.44(1.23~339.25) |
结核分枝杆菌耐药 | 2.92 | 1.25 | 5.49 | 0.019 | 18.57(1.61~213.77) |
并发其他部位结核 | 2.63 | 1.09 | 5.83 | 0.016 | 13.91(1.64~117.87) |
[1] |
孙荣, 陈峥宏 . 结核分枝杆菌耐药相关基因突变及其检测. 贵州医药, 2015,39(11):1043-1045.
doi: 10.3969/j.ISSN.1000-744X.2015.11.044 URL |
[2] |
邵川强 . 脊柱结核外科治疗进展. 中国矫形外科杂志, 2012,20(3):245-247.
doi: 10.3977/j.issn.1005-8478.2012.03.16 URL |
[3] |
Danesh-Clough T , Theis JC, van der Linden A . Mycobacterium xenopi infection of the spine: a case report and literature review. Spine (Phila Pa 1976), 2000,25(5):626-628.
doi: 10.1097/00007632-200003010-00015 URL |
[4] |
蒲育, 何敏, 蔡海东 , 等. 腰骶段脊柱结核的手术治疗. 中国骨肿瘤骨病, 2011,10(4):351-354.
doi: 10.3969/j.issn.1671-1971.2011.04.006 URL |
[5] | 吴启秋, 林羽 . 骨与关节结核. 北京: 人民卫生出版社, 2006: 160. |
[6] |
Bridwell KH, Lenke LG , McEnery KW, et al. Anterion fresh frozen structural allografts in the thoracic and lumbar spine. Do they work if combined with posterior fusion and instrumentation in adult patients with kyphosis or anterior column defects? Spine (phila Pa 1976), 1995,20(12):1410-1418.
doi: 10.1097/00007632-199506020-00014 URL |
[7] | 冯亚非, 卫磊, 赵晓蕾 , 等. 脊柱结核术后复发的治疗方案及临床疗效. 脊柱外科杂志, 2018,16(4):227-230. |
[8] | 秦世炳, 宋言峥, 董伟杰 . 骨关节结核临床诊断与治疗进展及其规范化专题研讨会纪要. 中国防痨杂志, 2013,35(1):83-84. |
[9] | 梁利川, 赵晨, 罗磊 , 等. 术后复发性胸腰椎结核的病例特点及临床意义. 实用骨科杂志, 2018,24(7):581-588. |
[10] |
吴启秋 . 脊柱结核的化学治疗. 中国脊柱脊髓杂志, 2004,14(12):766-768.
doi: 10.3969/j.issn.1004-406X.2004.12.020 URL |
[11] |
唐神结 . 耐药结核病诊治研究进展. 同济大学学报(医学版), 2010,31(4):1-4.
doi: 10.3969/j.issn.1008-0392.2010.04.001 URL |
[12] |
贾晨光, 刘丰胜, 姚黎明 , 等. 耐多药脊柱结核的临床应对措施. 河北医科大学学报, 2014,35(1):23-26.
doi: 10.3969/j.issn.1007-3205.2014.01.008 URL |
[13] |
姚晓伟, 董昭良, 李卓 , 等. 60例耐药脊柱结核患者个体化治疗及疗效的临床研究. 中国防痨杂志, 2016,38(11):978-984.
doi: 10.3969/j.issn.1000-6621.2016.11.017 URL |
[14] |
唐神结, 肖和平, 夏祥新 , 等. 不同年龄组结核分枝杆菌耐药性的研究. 中华结核和呼吸杂志, 2001,24(2):83-86.
doi: 10.3760/j:issn:1001-0939.2001.02.005 URL |
[15] |
李祯, 马远征, 秦世炳 . GeneXpert MTB/RIF技术的应用进展及其在骨关节结核诊断中的价值. 中国防痨杂志, 2016,38(4):322-326.
doi: 10.3969/j.issn.1000-6621.2016.04.019 URL |
[16] |
顾谨, 唐神结 . WHO耐药结核病治疗指南(2016更新版)要点解读. 结核病与肺部健康杂志, 2016,5(4):340-343.
doi: 10.3969/j.issn.2095-3755.2016.04.021 |
[17] |
王自立, 王骞 . 脊柱结核的手术策略. 中华骨科杂志, 2010,30(7):719-721.
doi: 10.3760/cma.j.issn.0253-2352.2010.07.020 URL |
[18] |
兰汀隆, 秦世炳 . 严格掌握脊柱结核手术指征并选择合适的手术时机和方式. 中国防痨杂志, 2017,39(4):327-328.
doi: 10.3969/j.issn.1000-6621.2017.04.002 |
[19] |
胡资兵, 曾荣, 魏波 , 等. 髂骨螺钉联合磷酸钙骨粉在腰骶椎结核中的应用. 中国临床解剖学杂志, 2015,16(3):349-353.
doi: 10.13418/j.issn.1001-165x.2015.03.025 URL |
[20] | 吴晓亮, 郑明辉, 马洋洋 , 等. 一期后路腰骶或腰骨盆重建治疗腰骶椎结核. 中国矫形外科杂志, 2018,26(13):1188-1193. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||